SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
miaoda
Lv1
30 积分
2022-10-07 加入
最近求助
最近应助
互助留言
Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC
27天前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
1个月前
已完结
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
1个月前
已完结
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update
1个月前
已关闭
Immune Checkpoint Inhibitor–Induced Cardiotoxicity A Systematic Review and Meta-Analysis
1个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
2个月前
已完结
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS)
2个月前
已完结
Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study
2个月前
已完结
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
2个月前
已完结
Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC)
2个月前
已关闭
没有进行任何应助
速度真快
27天前
已找到【积分已退回】
1个月前
速度真快
2个月前
帮大忙了
2个月前
帮大忙了
2个月前
速度真快
4个月前
么么哒
4个月前
速度真快
4个月前
帮大忙了
4个月前
速度真快
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论